New York, NY USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Leading Cancer Research Organizations to Host Cancer Immunotherapy Conference

Four leading cancer research organizations will host a conference dedicated to the latest in cancer immunotherapy.
15-Aug-2016 12:05 PM EDT Add to Favorites

Leading Cancer Research Organizations to Host Cancer Immunotherapy Conference

Media are encouraged to register to attend the second annual International Cancer Immunotherapy Conference organized by the Cancer Research Institute, Association for Cancer Immunotherapy, European Academy of Tumor Immunology, and the American...
3-Aug-2016 12:00 PM EDT Add to Favorites

Cancer Research Institute to Honor Three Scientists for Outstanding Contributions to Cancer Immunotherapy Research

Announcement of winners of the 2016 William B. Coley and Frederick W. Alt Awards, celebrating key scientific contributions to the fields of immunology, tumor immunology (also known as immuno-oncology), and cancer immunotherapy.
26-Jul-2016 1:00 PM EDT Add to Favorites

Cancer Research Institute Celebrates Fourth Annual Cancer Immunotherapy Month™ in June


Month-long educational and awareness initiative designed increase public awareness of the potential of cancer immunotherapy to treat and potentially cure all cancers.
1-Jun-2016 2:05 PM EDT Add to Favorites

Cancer Research Institute Hosts Answer to Cancer Cycling Event

One-day, multi-distance ride through the Lower Hudson Valley’s breathtaking landscape to raise funds for the nonprofit Cancer Research Institute and increase awareness of the potential of immunotherapy to cure all cancers.
12-May-2016 12:00 PM EDT Add to Favorites

Cancer Research Institute and Inspire Partner to Launch Online Immunotherapy Support Community

CRI and Inspire have partnered to launch a new cancer immunotherapy support community for patients and caregivers.
11-Apr-2016 10:00 AM EDT Add to Favorites

The History and Future of Cancer Immunotherapy

Immunotherapy is currently revolutionizing cancer treatment and, according to Axel Hoos, M.D., Ph.D., has the potential to improve patient outcomes significantly in the future. Dr. Hoos leads one of the Cancer Research Institute’s (CRI)...
23-Mar-2016 11:05 AM EDT Add to Favorites

Nivolumab Becomes First FDA-Approved Checkpoint Blockade for Kidney Cancer


New hope now exists for patients with advanced kidney cancer. Yesterday, the FDA approved the immunotherapy drug nivolumab (Opdivo®, Bristol-Myers Squibb) to treat metastatic renal cell carcinoma (RCC)—the most common form of kidney cancer—that...
2-Dec-2015 2:05 PM EST Add to Favorites

Our Experts on Newswise

Expert Available for Commentary on Recent FDA Analysis of TNF Blockers

The FDA announced on Aug 4 2009 that tumor necrosis factor (TNF) blockers used in the treatment of immune disorders carry an increased risk of lymphoma and other cancers in children and adolescents. The discoverer of TNF-alpha, Lloyd J. Old, M.D., a...
7-Aug-2009 9:00 AM EDT

PROVENGE Cancer Vaccine Heralds New Dawn in Cancer Therapy

Dendreon's PROVENGE for the treatment of advanced prostate cancer is the first active cellular immunotherapy to prolong patient survival, according to data from a pivotal phase III clinical trial announced at yesterday's AUA annual meeting in...
29-Apr-2009 11:20 AM EDT

Our YouTube Videos

Chat now!